429 419

Cited 8 times in

Rapid mycobacterial liquid culture-screening method for Mycobacterium avium complex based on secreted antigen-capture enzyme-linked immunosorbent assay

DC Field Value Language
dc.contributor.author신성재-
dc.date.accessioned2015-04-24T17:46:25Z-
dc.date.available2015-04-24T17:46:25Z-
dc.date.issued2009-
dc.identifier.issn1556-6811-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/106042-
dc.description.abstractSensors in automated liquid culture systems for mycobacteria, such as MGIT, BacT/Alert 3D, and Trek ESP II, flag growth of any type of bacteria; a positive signal does not mean that the target mycobacteria are present. All signal-positive cultures thus require additional and often laborious testing. An immunoassay was developed to screen liquid mycobacterial cultures for evidence of Mycobacterium avium complex (MAC). The method, called the MAC-enzyme-linked immunosorbent assay (ELISA), relies on detection of MAC-specific secreted antigens in liquid culture. Secreted MAC antigens were captured by the MAC-ELISA with polyclonal anti- Mycobacterium avium subsp. paratuberculosis chicken immunoglobulin Y (IgY), detected using rabbit anti-MAC IgG, and then revealed using horseradish peroxidase-conjugated goat anti-rabbit IgG. When the MAC-ELISA was evaluated using pure cultures of known mycobacterial (n = 75) and nonmycobacterial (n = 17) organisms, no false-positive or false-negative MAC-ELISA results were found. By receiver operator characteristic (ROC) analysis of 1,275 previously identified clinical isolates, at the assay optimal cutoff the diagnostic sensitivity and specificity of the MAC-ELISA were 92.6% (95% confidence interval [95% CI], 90.3 to 94.5) and 99.9% (95% CI, 99.2 to 100), respectively, with an area under the ROC curve of 0.992. Prospective evaluation of the MAC-ELISA with an additional 652 clinical samples inoculated into MGIT ParaTB medium and signaling positive per the manufacturer's instructions found that the MAC-ELISA was effective in determining those cultures that actually contained MAC species and warranting the resources required to identify the organism by PCR. Of these 652 MGIT-positive cultures, the MAC-ELISA correctly identified 96.8% (of 219 MAC-ELISA-positive cultures) as truly containing MAC mycobacteria, based on PCR or high-performance liquid chromatography (HPLC) as reference tests. Only 6 of 433 MGIT signal-positive cultures (1.4%) were MAC-ELISA false negative, and only 7 of 219 MGIT signal-negative cultures (3.2%) were false positive. The MAC-ELISA is a low-cost, rapid, sensitive, and specific test for MAC in liquid cultures. It could be used in conjunction with or independent of automated culture reading instrumentation. For maximal accuracy and subspecies-specific identification, use of a confirmatory multiplex MAC PCR is recommended-
dc.description.statementOfResponsibilityopen-
dc.format.extent613~620-
dc.relation.isPartOfClinical and Vaccine Immunology-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAntigens, Bacterial/immunology-
dc.subject.MESHAntigens, Bacterial/isolation & purification*-
dc.subject.MESHDiagnostic Errors-
dc.subject.MESHEnzyme-Linked Immunosorbent Assay/methods-
dc.subject.MESHMass Screening/methods*-
dc.subject.MESHMycobacterium avium Complex/genetics-
dc.subject.MESHMycobacterium avium Complex/growth & development-
dc.subject.MESHMycobacterium avium Complex/isolation & purification*-
dc.subject.MESHMycobacterium avium-intracellulare Infection/diagnosis-
dc.subject.MESHMycobacterium avium-intracellulare Infection/microbiology-
dc.subject.MESHMycobacterium avium-intracellulare Infection/veterinary*-
dc.subject.MESHParatuberculosis/diagnosis*-
dc.subject.MESHSensitivity and Specificity-
dc.titleRapid mycobacterial liquid culture-screening method for Mycobacterium avium complex based on secreted antigen-capture enzyme-linked immunosorbent assay-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Microbiology (미생물학)-
dc.contributor.googleauthorSung Jae Shin-
dc.contributor.googleauthorKelly Anklam-
dc.contributor.googleauthorElizabeth J. B. Manning-
dc.contributor.googleauthorMichael T. Collins-
dc.identifier.doi10.1128/CVI.00461-08-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02114-
dc.relation.journalcodeJ00559-
dc.identifier.pmid19261776-
dc.contributor.alternativeNameShin, Sung Jae-
dc.contributor.affiliatedAuthorShin, Sung Jae-
dc.citation.volume16-
dc.citation.number5-
dc.citation.startPage613-
dc.citation.endPage620-
dc.identifier.bibliographicCitationClinical and Vaccine Immunology, Vol.16(5) : 613-620, 2009-
dc.identifier.rimsid56996-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Microbiology (미생물학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.